Abbvie (ABBV) PT Lowered to $80 at Piper Jaffray
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Wolfe Research Upgrades Abbvie (ABBV) to Peerperform on Valuation
June 27, 2019 9:30 AM EDTWolfe Research analyst Tim Anderson upgraded Abbvie (NYSE: ABBV) from Underperform to Peerperform with a price target of $74.00 (from $84.00).
Cites the recent pullback in the valuation for the upgrade.For an analyst ratings summary and ratings history on... More
